Navigation Links
India should increase precautionary measures against Bird flu

India's Wait and Watch Policy against preparing for Bird flu epidemic may be very risky in a situation when all other countries are taking intensified precautionary measures for curbing in case of a bird flu outbreak. Even the World Health Organization has asked India to beef up // its precautionary measures to avoid an epidemic.

India has a bird flu threat this winter from china due to spread from migratory birds like wild duck and fowl as these wild ducks and fowls are natural reservoirs of avian flu and unlike chicken, they don't die of it and when these birds come in contact with domestic chicken, they spread the virus. The Animal Disease Laboratory is testing diseases among animals and has confirmed that not even a single strain of the deadly H5N1 virus has been isolated in India in the last five years.

Swiss drug firm Roche has the manufacturing patent for Tamiflu and it is not compromising on its patent though request from various countries as the tablets produced by Roche would cost Rs. 180/tablet. If Generic drugs are allowed to be manufactured it will reduce the cost of the drug ’s representatives who were recently in India, the Indian government had failed to convince them to allow Indian pharma companies for generic version of Tamiflu. Roche has the patent for Tamiflu, the only known drug for bird flu, and its market price is Rs 180 per tablet and four pharmaceutical companies Teva Pharmaceuticals, Mylan Laboratories, Barr Laboratories and Ranbaxy are interested to manufacture the generic version of Tamiflu if Roche compromises on its patent. Indian Pharmaceutical company Cipla has manufactured an antiviral drug for bird flu called Zanamivir (Relenza) which is more cheaper and an alternative to Tamiflu.


'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility ... Hong Kong to support teaching, learning and research. It is also the largest research ... Hong Kong. , With an area of 620 square metres and more than ...
(Date:4/21/2017)... ... 21, 2017 , ... Airway Management, the medical device manufacturer ... regarded and well renowned Asian distributor, Discovery Sleep. The agreement involves ... Mask, and will stabilize and strengthen Airway’s presence with a dedicated, reputable medical ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... Providing ... not understand the estate planning process, or where to even begin. “Now more than ... if you are to properly protect yourself and your family,” said attorney Lisa Edgar ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Each year, everyone ... a day to clean, plant trees and look forward to a better future. However, ... about doing something outdoors. Indoor air quality can be two to five times more ...
(Date:4/21/2017)... ... April 21, 2017 , ... Indiana ... significant bandwidth upgrade infrastructure service to Tele-Media Solutions. IFN is delivering Multi-Gigabit ... IFN’s consortium member-owners, Tele-Media Solution’s protect transport with 3GB Dual Access Internet access ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
Breaking Medicine Technology: